Stock Research: Hypera

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Hypera

BOVESPA:HYPE3 BRHYPEACNOR0
63
  • Value
    14
  • Growth
    49
  • Safety
    Safety
    97
  • Combined
    62
  • Sentiment
    48
  • 360° View
    360° View
    63
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Hypera SA is a pharmaceutical company operating in several markets with a variety of pharmaceutical products. The company operates in the pharmaceuticals sector and offers brands such as Mantecorp Farmasa, Addera D3, and Mantecorp Skincare, among others. It operates primarily in Brazil. In the last fiscal year, the company had a market cap of $3,123 million, profits of $709 million, and revenue of $1,205 million. The number of employees is not available.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 63 (better than 63% compared with alternatives), overall professional sentiment and financial characteristics for the stock Hypera are above average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Hypera. Only the consolidated Value Rank has an attractive rank of 97, which means that the share price of Hypera is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 97% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 49, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 14, meaning the company has a riskier financing structure than 86% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 52% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 48. ...read more

more
Index
BOVESPA
Human Rights
Renewables Users
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
97 91 95 93
Growth
49 33 9 23
Safety
Safety
14 33 27 27
Sentiment
48 25 47 96
360° View
360° View
63 39 26 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
54 36 55 67
Opinions Change
34 15 11 50
Pro Holdings
n/a 50 77 98
Market Pulse
37 40 54 71
Sentiment
48 25 47 96
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
97 91 95 93
Growth
49 33 9 23
Safety Safety
14 33 27 27
Combined
62 57 31 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
100 93 93 97
Price vs. Earnings (P/E)
83 79 71 78
Price vs. Book (P/B)
81 82 82 88
Dividend Yield
94 94 96 82
Value
97 91 95 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
96 29 26 79
Profit Growth
14 23 34 38
Capital Growth
55 84 39 21
Stock Returns
23 13 13 13
Growth
49 33 9 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
11 10 10 16
Refinancing
45 88 78 82
Liquidity
27 34 32 34
Safety Safety
14 33 27 27

Similar Stocks

Discover high‑ranked alternatives to Hypera and broaden your portfolio horizons.

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Lojas Renner

BOVESPA:LREN3
Country: Brazil
Industry: Apparel Retail
Size: Medium
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.